HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Sara Colombetti Selected Research
Sara Colombetti Research Topics
Disease
16
Neoplasms (Cancer)
03/2024 - 01/2006
2
Hematologic Neoplasms (Hematological Malignancy)
12/2019 - 10/2018
2
Melanoma (Melanoma, Malignant)
07/2012 - 01/2006
1
Lymphoma (Lymphomas)
03/2024
1
Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2024
1
Glioblastoma (Glioblastoma Multiforme)
10/2022
1
Persistent Infection
10/2022
1
Disease Progression
01/2021
1
Renal Cell Carcinoma (Grawitz Tumor)
11/2020
1
Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
11/2020
Drug/Important Bio-Agent (IBA)
5
Bispecific Antibodies
IBA
01/2024 - 12/2019
5
cibisatamab
IBA
01/2021 - 01/2016
4
Antigens
IBA
10/2022 - 01/2006
4
Carcinoembryonic Antigen
IBA
01/2021 - 01/2016
3
Cytokines
IBA
10/2022 - 01/2021
2
Antibodies
IBA
01/2020 - 10/2018
1
glofitamab
IBA
03/2024
1
Azacitidine (5 Azacytidine)
FDA Link
01/2024
1
venetoclax
IBA
01/2024
1
ErbB Receptors (EGF Receptor)
IBA
10/2022
1
epidermal growth factor receptor VIII
IBA
10/2022
1
T-Cell Antigen Receptors (T-Cell Receptor)
IBA
10/2022
1
Interleukins
IBA
10/2022
1
Lymphocyte Function-Associated Antigen-1 (LFA-1)
IBA
01/2021
1
Biomarkers (Surrogate Marker)
IBA
01/2021
1
N- propyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (PPTP)
IBA
01/2021
1
atezolizumab
IBA
11/2020
1
Blocking Antibodies
IBA
11/2020
1
Granzymes (Granzyme)
IBA
12/2019
1
Proteins (Proteins, Gene)
FDA Link
12/2019
1
Neoplasm Antigens (Tumor Antigens)
IBA
12/2019
1
obinutuzumab
IBA
10/2018
1
Immunoglobulin G (IgG)
IBA
01/2016
Therapy/Procedure
5
Immunotherapy
01/2021 - 01/2006
3
Therapeutics
01/2021 - 07/2012
1
Investigational Therapies (Experimental Therapy)
01/2021
1
Aftercare (After-Treatment)
09/2016